TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells.
Wang H, Sica RA, Kaur G, Galbo PM Jr, Jing Z, Nishimura CD, Ren X, Tanwar A, Etemad-Gilbertson B, Will B, Zheng D, Fooksman D, Zang X.
Wang H, et al. Among authors: tanwar a.
Nat Commun. 2024 Jan 2;15(1):11. doi: 10.1038/s41467-023-43843-6.
Nat Commun. 2024.
PMID: 38167704
Free PMC article.